Rank;Global Rank;Institution;Country;Sector
1;85;Hoffmann-La Roche, GmbH., Germany;DEU;Companies
2;95;Novartis Farma, S.p.A., Italy;ITA;Companies
3;162;Hoffmann-La Roche, Ltd., Switzerland;CHE;Companies
4;171;Novartis Institutes for Biomedical Research, Switzerland;CHE;Companies
5;195;Novartis, Switzerland;CHE;Companies
6;213;Novo Nordisk A/S;DNK;Companies
7;218;AstraZeneca, United Kingdom;GBR;Companies
8;220;Merck KGaA, Germany;DEU;Companies
9;230;GlaxoSmithKline, United Kingdom;GBR;Companies
10;282;Pfizer Inc., United Kingdom;GBR;Companies
11;392;IMEC International;BEL;Companies
12;488;AstraZeneca, Sweden;SWE;Companies
13;492;GlaxoSmithKline, Belgium;BEL;Companies
14;503;Bayer AG, Germany;DEU;Companies
15;595;Sanofi-Aventis, Germany;DEU;Companies
16;611;Bruker Corp;DEU;Companies
17;782;Eli Lilly and Company Ltd., United Kingdom;GBR;Companies
18;1034;France Telecom, S.A.;FRA;Companies
19;1203;Telecom Italia S.p.A.;ITA;Companies
20;1250;Carl Zeiss AG;DEU;Companies
21;1933;SINTEF Group;NOR;Companies
22;2142;Robert Bosch GmbH;DEU;Companies
23;2155;BMW AG;DEU;Companies
24;2601;Renault, S.A.S.;FRA;Companies
25;2685;European XFEL GmbH;DEU;Companies
26;3325;Sincrotrone Trieste;ITA;Companies
27;3821;Daimler AG;DEU;Companies
28;3882;Fusion for Energy;ESP;Companies
29;4069;Electricite de France, S.A.;FRA;Companies
30;4814;Intesa Sanpaolo S.p.A.;ITA;Companies
31;4905;Atomic Weapons Establishment;GBR;Companies
32;5053;ARUP;GBR;Companies
32;5053;BMJ Group;GBR;Companies